Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces apoptosis in nonproliferating macrophages by a phosphatase-independent mechanism

Infection and Immunity

Volumn 77, Issue 8, 2009, Pages 3161-3169

  Rabin, Shira D P ^a   Flitton, Jared G ^a   Demuth, Donald R ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOLETHAL DISTENDING TOXIN; CYTOLETHAL DISTENDING TOXIN B; DEOXYRIBONUCLEASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE PHOSPHATASE; UNCLASSIFIED DRUG;

ACTINOBACILLUS; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

APOPTOSIS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL LINE; DEOXYRIBONUCLEASES; HUMANS; MACROPHAGES; MUTAGENESIS, SITE-DIRECTED; PASTEURELLACEAE; PHOSPHORIC MONOESTER HYDROLASES;

EID: 67651229415     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01227-08     Document Type: Article

References (48)

1. Ahmed, H. J., L. A. Svensson, L. D. Cope, J. L. Latimer, E. J. Hansen, K. Ahlman, J. Bayat-Turk, D. Klamer, and T. Lagergard. 2001. Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J. Med. Microbiol. 50:860-864.
2. Akifusa, S., W. Heywood, S. P. Nair, G. Stenbeck, and B. Henderson. 2005. Mechanism of internalization of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiology 151:1395-1402.
3. Akifusa, S., S. Poole, J. Lewthwaite, B. Henderson, and S. P. Nair. 2001. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect. Immun. 69: 5925-5930.
4. Arcila, M. L., M. D. Sanchez, B. Ortiz, L. F. Barrera, L. F. Garcia, and M. Rojas. 2007. Activation of apoptosis, but not necrosis, during Mycobacterium tuberculosis infection correlated with decreased bacterial growth: role of TNF-α-, IL-10, caspases and phospholipase A2. Cell. Immunol. 249:80-93.
5. Belibasakis, G., A. Johansson, Y. Wang, R. Claesson, C. Chen, S. Asikainen, and S. Kalfas. 2002. Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. Eur. J. Oral Sci. 110:366-373.
6. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Cortes-Bratti, X., C. Karlsson, T. Lagergard, M. Thelestam, and T. Frisan. 2001. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J. Biol. Chem. 276:5296-5302.
8. DiRienzo, J. M., M. Song, L. S. Wan, and R. P. Ellen. 2002. Kinetics of KB and HEp-2 cell responses to an invasive, cytolethal distending toxin-producing strain of Actinobacillus actinomycetemcomitans. Oral Microbiol. Immunol. 17:245-251.
9. Elwell, C. A., and L. A. Dreyfus. 2000. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 37:952-963.
10. Fabris, A. S., J. M. DiRienzo, M. Wikstrom, and M. P. Mayer. 2002. Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations. Oral Microbiol. Immunol. 17:231-238.
11. Fernandes, K. P., M. P. Mayer, E. S. Ando, A. G. Ulbrich, J. G. Amarente-Mendes, and M. Russo. 2008. Inhibition of interferon-γ- induced nitric oxide production in endotoxin-activated macrophages by cytolethal distending toxin. Oral Microbiol. Immunol. 23:360-366.
12. Fine, D. H., D. Furgang, H. C. Schreiner, P. Goncharoff, J. Charlesworth, G. Ghazwan, P. Fitzgerald-Bocarsly, and D. H. Figurski. 1999. Phenotypic variation in Actinobacillus actinomycetemcomitans during laboratory growth: implications for virulence. Microbiology 145:1335- 1347.
13. Fine, D. H., P. Goncharoff, H. Schreiner, K. M. Chang, D. Furgang, and D. Figurski. 2001. Colonization and persistence of rough and smooth colony variants of Actinobacillus actinomycetemcomitans in the mouths of rats. Arch. Oral Biol. 46:1065-1078.
14. Frisk, A., M. Lebens, C. Johansson, H. Ahmed, L. Svensson, K. Ahlman, and T. Lagergard. 2001. The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity. Microb. Pathog. 30:313-324.
15. Gemmell, E., K. Yamazaki, and G. J. Seymour. 2007. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol. 2000 43: 14-40.
16. Hickey, T. E., G. Majam, and P. Guerry. 2005. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytolethal distending toxin. Infect. Immun. 73:5194-5197.
17. Jotwani, R., and C. W. Cutler. 2003. Multiple dendritic cell (DC) subpopulations in human gingiva and association of mature DCs with CD4+ T-cells in situ. J. Dent. Res. 82:736-741.
18. Jotwani, R., A. K. Palucka, M. Al-Quotub, M. Nouri-Shirazi, J. Kim, D. Bell, J. Banchereau, and C. W. Cutler. 2001. Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J. Immunol. 167:4693-4700.
19. Kamen, P. R. 1983. Inhibition of keratinocyte proliferation by extracts of Actinobacillus actinomycetemcomitans. Infect. Immun. 42:1191-1194.
20. Kang, P., J. Korostoff, A. Volgina, W. Grzesik, and J. M. DiRienzo. 2005. Differential effect of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans on co-cultures of human oral cells. J. Med. Microbiol. 54:785-794.
21. Kolodrubetz, D., T. Dailey, J. Ebersole, and E. Kraig. 1989. Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans. Infect. Immun. 57:1465-1469.
22. Lai, J. P., J. T. Dalton, and D. L. Knoell. 2007. Phosphatase and tensin homologue deleted on chromosome ten (PTEN) as a molecular target in lung epithelial wound repair. Br. J. Pharmacol. 152:1172-1184.
23. Lally, E. T., I. R. Kieba, D. R. Demuth, J. Rosenbloom, E. E. Golub, N. S. Taichman, and C. W. Gibson. 1989. Identification and expression of the Actinobacillus actinomycetemcomitans leukotoxin gene. Biochem. Biophys. Res. Commun. 159:256-262.
24. Lara-Tejero, M., and J. E. Galan. 2000. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290:354-357.
25. Lara-Tejero, M., and J. E. Galan. 2001. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect. Immun. 69:4358-4365.
26. Li, L., A. Sharipo, E. Chaves-Olarte, M. G. Masucci, V. Levitsky, M. Thelestam, and T. Frisan. 2002. The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell. Microbiol. 4:87-99.
27. Mao, X., and J. M. DiRienzo. 2002. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell. Microbiol. 4:245-255.
28. Mayer, M. P., L. C. Bueno, E. J. Hansen, and J. M. DiRienzo. 1999. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect. Immun. 67:1227-1237.
29. 2/M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 73:4846-4852.
30. Molmeret, M., S. D. Zink, L. Han, A. Abu-Zant, R. Asari, D. M. Bitar, and Y. Abu Kwaik. 2004. Activation of caspase-3 by the Dot/Icm virulence system is essential for arrested biogenesis of the Legionella-containing phagosome. Cell. Microbiol. 6:33-48.
31. Nesić, D., Y. Hsu, and C. E. Stebbins. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433.
32. Page, R. C., and H. E. Schroeder. 1976. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab. Investig. 34:235-249.
33. Saiki, K., T. Gomi, and K. Konishi. 2004. Deletion and purification studies to elucidate the structure of the Actinobacillus actinomycetemcomitans cytolethal distending toxin. J. Biochem. (Tokyo) 136:335-342.
34. Saiki, K., K. Konishi, T. Gomi, T. Nishihara, and M. Yoshikawa. 2001. Reconstitution and purification of cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiol. Immunol. 45:497-506.
35. Shenker, B. J., D. R. Demuth, and A. Zekavat. 2006. Exposure of lymphocytes to high doses of Actinobacillus actinomycetemcomitans cytolethal distending toxin induces rapid onset of apoptosis-mediated DNA fragmentation. Infect. Immun. 74:2080-2092.
36. Shenker, B. J., M. Dlakic, L. P. Walker, D. Besack, E. Jaffe, E. LaBelle, and K. Boesze-Battaglia. 2007. A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J. Immunol. 178:5099-5108.
37. Shenker, B. J., R. H. Hoffmaster, A. Zekavat, N. Yamaguchi, E. T. Lally, and D. R. Demuth. 2001. Induction of apoptosis in human T cells by Actinobacillus actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J. Immunol. 167:435-441.
38. Shenker, B. J., M. E. Kushner, and C. C. Tsai. 1982. Inhibition of fibroblast proliferation by Actinobacillus actinomycetemcomitans. Infect. Immun. 38: 986-992.
39. Shenker, B. J., T. McKay, S. Datar, M. Miller, R. Chowhan, and D. Demuth. 1999. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J. Immunol. 162:4773-4780.
40. Slots, J., H. S. Reynolds, and R. J. Genco. 1980. Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect. Immun. 29:1013-1020.
41. Sugai, M., T. Kawamoto, S. Y. Peres, Y. Ueno, H. Komatsuzawa, T. Fujiwara, H. Kurihara, H. Suginaka, and E. Oswald. 1998. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 66:5008-5019.
42. Svensson, L. A., A. Tarkowski, M. Thelestam, and T. Lagergard. 2001. The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response. Microb. Pathog. 30:157-166.
43. Tan, K. S., K. P. Song, and G. Ong. 2002. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease. J. Periodontal Res. 37:268-272.
44. Ueno, Y., M. Ohara, T. Kawamoto, T. Fujiwara, H. Komatsuzawa, E. Oswald, and M. Sugai. 2006. Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin. Infect. Immun. 74:3480-3487.
45. van Winkelhoff, A. J., and J. Slots. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol. 2000 20:122-135.
46. Xu, T., A. Lundqvist, H. J. Ahmed, K. Eriksson, Y. Yang, and T. Lagergard. 2004. Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4+ T cells. Microbes Infect. 6:1171-1181.
47. Zambon, J. J. 1985. Actinobacillus actinomycetemcomitans in human periodontal disease. J. Clin. Periodontol. 12:1-20.
48. Zambon, J. J., J. Slots, and R. J. Genco. 1983. Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease. Infect. Immun. 41:19-27.